There are two main ways in which CSB could be used in chemotherapy: the first would be to use CSB as a biomarker, and the second would be to use an inhibitor of CSB to enhance tumour cell death in response to chemotherapy or endogenous sources of replication stress. Here, ERCC6 is linked to neoplasm.